The rodent S100-related calcium-binding protein, S100A4 induces metastasis in non-metastatic rat and mouse benign mammary cells and co-operates with benign-tumour-inducing changes in two transgenic mouse models, to yield metastatic mammary tumours. Cotransfection of the human gene for S100A4 with pSV2neo into the benign rat mammary cell line, Rama 37, yielded cells which expressed a low level of the endogenous S100A4 mRNA, and either high or undetectable levels of human S100A4 mRNA. The cells which expressed a high level of human S100A4 mRNA induced metastasis in the benign rat mammary cell line Rama 37 in an in vivo assay, whereas the cells which expressed an undetectable level of human S100A4 did not induce any detectable metastases. The primary tumours arising from the S100A4-expressing cells contained high levels of immunocytochemically-detected S100A4 and this high level of S100A4 and the metastatic potential were maintained when cells from a metastasis were re-injected into syngeneic rats. The results show that the human S100A4 possesses metastasis-inducing capabilities.
Introduction
The process of metastasis is the predominant cause of death in patients suering from the common solid cancers. Although some proteins associated with the process of metastasis have been identi®ed, there is little information on proteins and their genes which can cause metastasis in human cancers. In rodent systems, such a gene and its protein product have been identi®ed, namely S100A4, also known previously as p9Ka, mts1, pEL98, 18A2, 42A (Barraclough et al., 1987b; Ebralidze et al., 1989; Goto et al., 1988; Jackson-Grusby et al., 1987; Masiakowski and Shooter, 1988) . In cultured mammary cells of mouse (Ebralidze et al., 1989) and rat (Dunnington, 1984) , the level of S100A4 or its mRNA correlates with the metastatic potential of the cells. Furthermore, transfection of the rat S100A4 gene into diploid benign rat mammary epithelial cells and expression of S100A4, confers on the cells stable metastatic capability , suggesting that elevated expression of S100A4 can cause metastasis in a benign, tumorigenic, but non-metastatic cell line. This interpretation is strengthened by the observation that transgenic mice, expressing elevated levels of S100A4 (p9Ka) from 17 additional, position-independent rat S100A4 transgenes, fail to show any detectable phenotype (Davies, 1993) . When these mice are mated with transgenic mice containing additional copies of the activated rodent cerbB-2 oncogene, neu, under the control of the MMTV LTR (Bouchard et al., 1989) , ospring inheriting the neu oncogene suer sporadic mammary tumours after 12 ± 14 months of repeated mating. In contrast ospring inheriting both neu and S100A4 transgenes show an elevated incidence of primary tumours, and, in addition, metastases in the lungs which account for up to 24% of the total lung area (Davies et al., 1996) . A similar induction of metastasis by mouse S100A4 (mts1) transgenes has been obtained in a mouse strain exhibiting a high incidence of spontaneous benign mammary tumours .
The human gene for S100A4 occurs in a cluster of S100 genes on chromosome 1 (Engelkamp et al., 1993) , a region of the human genome which is often ampli®ed in breast cancer (Devilee et al., 1991; Dutrillaux et al., 1990; Gendler et al., 1990; Merlo et al., 1989; Micale et al., 1994; Pandis et al., 1992) , and elevated levels of S100A4 mRNA have been associated with malignant, relative to benign, breast tumours (Lloyd et al., submitted) . However, it is not yet known whether the human S100A4 gene has the same metastasis-inducing properties as its rodent counterparts , when it is overexpressed in non-metastatic epithelial cells. Here we have isolated, characterised and examined the eect of transfecting the human S100A4 gene into a benign rat mammary epithelial cell line on its tumorigenic and metastatic properties when introduced into syngeneic rats in vivo.
Results

Transfection of Rama 37 cells with the human S100A4 gene
Transfection of Rama 37 cells with either pSV2neo or pSV2neo and pBL307 (see Materials and methods) yielded 66 ± 80 colonies of 1 ± 5 mm diameter after a 14-day period in the presence of Geneticin, corresponding to a transfection frequency of 6.9 ± 7.0610 75 . Parallel transfection experiment controls, in which the pSV2neo was omitted, produced no observable surviving cells after 14 days.
Rama 37 cells co-transfected with pSV2neo and pBL307 were designated S-R37, whilst cells transfected with pSV2neo alone were designated neo-R37. Cell transfectants from each experiment were pooled, creating two pools of neo-R37, namely neo1-R37 and neo2-R37, and six pools of S-R37, namely S1-R37 ± S6-R37, each containing 5 ± 10 transfectant clones. Quantitative determination of the level of S100A4 DNA in high molecular weight DNA isolated from transfectant pools showed that the neo1-R37 cells contained the same number of copies of the S100A4 gene as the recipient Rama 37 cells, and the transfectant pools S5-R37 and S3-R37 respectively 50 and 15 more copies of the S100A4 gene than the nontransfected Rama 37 cells or normal human lymphocytes (Figure 1 ).
Levels of human and rat S100A4 mRNAs in transfected cells
The Rama 37 cells used for transfection contained levels of mRNA for S100A4 that were undetectable using Northern blotting procedures (Figure 2a) . Only a low level of S100A4 mRNA was detectable in the Rama 37 cells transfected with the selectable plasmid pSV2neo (1.03 relative to parental Rama 37 cells when corrected for the level of constitutively-expressed 36B4 mRNA). However, pools of Rama 37 cells cotransfected with pSV2neo and the human S100A4 gene expressed varying levels of the mRNA for S100A4. In order to ®nd out whether this increased level of S100A4 mRNA was a product of the transfected human gene or of the endogenous rat gene, reverse transcription polymerase chain reaction (RT ± PCR) was carried out on RNA from Rama 37 cells and the pools of transfected cells using primer pairs speci®c for the rat or human mRNAs for S100A4. The rat-speci®c primers did not amplify any human S100A4 mRNA in the RNA from the MDA-MB-231 cells, which express a high level of S100A4 mRNA (Lloyd et al., unpublished observation), but showed that there was a consistent, but low, level of rat S100A4 mRNA both in the Rama 37 cells, as described previously for S100A4 protein (Barraclough et al., 1984a) and in the transfected derivatives. The contrast between the results of the Northern blotting experiments and the RT ± PCR experiments on the cell line, Rama 37, re¯ects the improved sensitivity of the latter technique over the former. In contrast, the human-speci®c primers ampli®ed cDNA from the human S100A4-containing human cell line, MDA-MB-231, but not from cDNA from the rat-derived cell line Rama 37 (Figure 2b) , showing that both the rat and human primer pairs yielded species-speci®c ampli®cation of S100A4.
RNA from cell pools S3-R37 and S5-R37, arising from the co-transfection of Rama 37 cells with pSV2neo/human S100A4 gene construct, pBL307, contained a similarly low level of ampli®able rat S100A4 mRNA as the parental Rama 37 cells ( Figure  2b ). In contrast, with the human speci®c primers, RNA from pool S3-R37 showed little ampli®ed product whereas pool S5-R37 exhibited a strong band of ampli®ed DNA (Figure 2b ). This result strongly suggests that the high levels of S100A4 mRNA observed in S5-R37 RNA by Northern blotting was predominantly the product of the transfected human S100A4 gene, whereas pool S3-R37 was expressing levels of human S100A4 mRNA that were virtually undetectable even using the sensitive PCR techniques employed.
Incidence and metastatic properties of tumours arising from transfected cell lines
The single subcutaneous injection of Wistar-Firth rats with the parental cell line Rama 37, yielded primary tumours with an incidence of almost 85% and a median latent period of 33 days (Table 1) . This tumour incidence is somewhat higher than obtained previously with this cell line . However, the latent period is broadly similar to that obtained previously . The results obtained from the subcutaneous injection of neo-1-R37, Rama 37 cells transfected with pSV2neo alone, showed a tumour incidence of 40% and a median latent period of 30 days; results that were similar to those obtained before (Table 1 ). The parental Figure 1 Quanti®cation of the number of copies of the S100A4 (p9Ka) gene in cell line Rama 37 and derivative transfectant cell pools. Serial 5-fold dilutions of high-molecular-weight DNA isolated from Rama 37 cells and pools of transfected cells were applied to a nylon ®lter using a slot blot apparatus and the ®lter was hybridized with a human S100A4 gene-speci®c probe. Slots in row (a) contain 5 mg DNA from human lymphocytes (lane 1), 1 mg DNA from Rama 37 cells (lane 2), 1 mg DNA from neo1-R37 transfectants (lane 3), 1 mg DNA from S5-R37 transfectants (lane 4) and 1 mg DNA from S3-R37 transfectants (lane 5). Rows (b), (c) and (d) contain respectively ®vefold, 25-fold and 125-fold less DNA than that in the row (a) sample Figure 2 Detection of S100A4 and 36B4 mRNAs by Northern blotting and rat and human S100A4 mRNAs by RT ± PCR. (a) Samples of RNA from Rama 37 cells (lane 1), pool neo1-R37 (lane 2) arising from Rama 37 cells transfected with pSV2neo, pools S3 R37 (lane 3) and pool S5-R37 (lane 4), arising from the cotransfection of Rama 37 cells with pSV2neo and the human S100A4 gene, were subjected to denaturing agarose gel electrophoresis and the fractionated RNA transferred to nylon membranes. The ®lters were incubated with a human S100A4-gene-speci®c probe (i) and a probe for the constitutively-expressed mRNA for the ribosomal phosphoprotein 36B4 (ii). Hybridizing radioactivity was detected by autoradiography. (b) RNA isolated from the S100A4-expressing human mammary carcinoma cell line MDA-MB-231 (lane 1), pools S3-R37 (lane 2) and S5-R37 (lane 3) of Rama 37 cells cotransfected with pSV2neo and the human S100A4 gene, pool neo1-R37 (lane 4) or no RNA (lane 5) were subjected to RT ± PCR using primers speci®c for human (i) or rat (ii) S100A4 mRNA. The resulting products were subjected to agarose gel electrophoresis and the ampli®ed DNA was visualized by being stained with ethidium bromide Rama 37 cells and pSV2neo transfectants failed to form any secondary tumours or microscopic lesions, con®rmed by histological examinations of tissues likely to be involved with tumour cell metastasis, namely lungs, lymph nodes, liver, spleen and kidney.
One pool of cells, S3-R37, which arose from cotransfection of Rama 37 cells with pSV2neo and the S100A4-bearing plasmid, pBL307, produced almost undetectable levels of rat S100A4 mRNA and no detectable PCR-ampli®able human S100A4 mRNA (Figure 2 ). These cells yielded primary tumours with an incidence of 80% upon inoculation into the mammary glands of syngeneic rats, a value that was not signi®cantly dierent from that obtained with untransfected Rama 37 cells in these same experiments (P40.04, Fisher exact test), and failed to produce any metastases ( Table 1 ). The pool of transfected cells that expressed the mRNA for human S100A4, pool S5-R37, yielded a tumour incidence of 77.5% upon inoculation into syngeneic rats, a value that was not signi®cantly dierent from that obtained with Rama 37 cells (P40.4, Fisher exact test), nor with the S3-R37 pool (P40.5, Fisher exact test). It also displayed a slight, but signi®cant reduction in latent period when compared with that of the parental Rama 37 cells (P50.008, Mann ± Whitney U-test). However, in contrast, S5-R37 cells formed a signi®cant number of metastatic lesions (20/30) compared to the parental Rama 37 cells and pSV2neo-transfected cells (P50.0001, Fisher exact test).
Cells from a primary tumour (pt), induced by the injection of S5-R37 cells, were re-established in culture and designated S5-pt. The cells maintained their resistance to Geneticin in culture. Injection of S5-pt cells in the mammary fat pads of syngeneic rats resulted in a statistically signi®cant reduction of the median latent period to 14 days upon comparison with S5-R37 cells (P50.02, Mann ± Whitney U-test). Despite this, the incidence of primary tumours produced by the injection of S5-pt cells was not statistically signi®cantly dierent from either that of the Rama 37 cells alone (P40.4, Fisher exact test) or S5-R37 cells (P40.14, Fisher exact test) ( Table 2 ). The cells maintained their metastatic capability, however, and the incidence of metastases was also not signi®cantly dierent from that of S5-R37 (P=0.126, Fisher exact test).
The re-establishment of tumour cells from a lung colony of a metastasis arising from S5-pt cells resulted in the isolation of a cell line designated S5-lc that was also resistant to the drug Geneticin. Introduction of the isolated cell line into the mammary glands of syngeneic rats resulted in a tumour incidence of 88%, a value not signi®cantly dierent from that of either the parental Rama 37 cells (P40.5, Fisher exact test) or the S5-R37 cells (P=0.235, Fisher exact test). However, the latent period (7 days) was signi®cantly shorter than both Rama 37 cells and S5-R37 cells (P50.0001, Mann ± Whitney U-test). The incidence of metastases of the S5-lc cell line (36%), while still being signi®cantly more than that of the Rama 37 cells (P50.003, Fisher exact test) was signi®cantly less than the 67% obtained with S5-R37 (P50.05, two-tailed Fisher exact test). These results suggest that there is not a link between a short latent period and the incidence of metastases in this system.
Pathology of tumours and metastases originating from transfected cells
Most of the S100A4 transfectants, whether passaged in the animal (Table 2) or not (Table 1) , produced rather (Figure 3a) . The tumours produced by the S3-R37 transfectants were usually encapsulated and were not invasive, similar to the tumours produced by the control neo1-R37 and parental Rama 37 cells, whereas tumours produced by S5-R37 cells and their derivative cell lines contained virtually no capsule and were highly invasive of fat and muscle (Figure 3a) . The metastases produced by S5-R37 cells and their derivative cell lines were found, on histological examination of relevant organs, only in the lungs, although a few local lymph nodes in the mammary gland associated with the primary tumour also contained tumour cells. The metastases in the lungs varied in size from small multiple (5 or 6), to large cannon-balls a few millimetres in diameter (Figure 3b ), up to larger numbers (20 ± 30) of diuse micrometastases which predominantly surrounded blood vessels (Figure 3c ). Both types of metastases could occur in the same lung of a tumour-bearing animal. Nonneoplastic perivascular and peribronchial aggregates of lymphocytes were common in many of the lungs examined. However, lymphocytic aggregates were distinguishable from tumour cells by their nuclei, which were more uniform with condensed chromatin and they were generally less tightly-packed than tumour cells in metastatic deposits. Suspect lesions detected by histological examination were con®rmed by successful re-establishment of tumour cells in culture from primary cultures of tissues containing these lesions. In order to eliminate contaminating host cells such as ®broblasts, which grow for a limited time in culture, these primary cultures were grown for several passages in Geneticin-containing medium. Only those tissues which contained histologically-identi®able lesions produced permanently growing cell lines in culture.
The tumours and metastases produced by S5-R37 transfectants and their derivative cell lines often had a pseudoglandular appearance due to their high degree of vascularisation (Figure 3d ) whereas the tumours arising from control neo1-R37 cells contained some epithelial-like cells arranged in glandular formations, like the tumours produced by their parental Rama 37 cells. The neo1-R37 and Rama 37 tumour cells were cytologically benign with uniform nuclei and normal mitotic ®gures, in contrast to the highly variable morphology of the spindle/intermediate cells of the S5-R37 tumours/metastases which possessed irregularly darkly stained nuclei, aberrant mitotic ®gures and higher nuclear/cytoplasmic ratios. Histological examination revealed that all tumours produced by S3-R37, neo1-R37 and Rama 37 cells failed to metastasize to lungs or lymph nodes in syngeneic rats and this was con®rmed by the failure to grow tumour cells in culture from these tissues. Isolated groups or single tumour cells were observed in the lungs of S5-R37 or derivative tumour-bearing rats both in vascular spaces containing blood cells (Figure 3e) , presumably blood vessels, and in vascular spaces containing lymphocytes (Figure 3f ), presumably lymphatics.
Immunocytochemical staining of primary tumours and metastases produced by S5-R37 transfectants and their derivative cell lines largely con®rmed the histological results. These lesions contained no surrounding laminin-staining basement membrane, although there was a profusion of laminin-staining blood vessels, particularly at their leading edges (Figure 4a) . The tumour cells could be stained for three markers of epithelial cells, with antibodies to rat MFGM in a variable manner, usually cytoplasmic (Figure 4b) , with antibodies to human callus keratin (Figure 4c) , and with peanut lectin usually membranously, but sometimes cytoplasmically (Figure 4d) . The tumour cells could also be stained with antibodies to vimentin (Figure 4e ), but not with antibodies to smooth muscle actin (Figure 4f ), both markers of myoepithelial cells.
In the benign tumours produced by the parental Rama 37 cells and the control neo1-R37 transfectants, antibodies to rat S100A4 stained weakly the few myoepithelial-like cells but not the glandular epithelial cells (Figure 5a ). However the tumours and metastases produced by the S5-R37 transfectants and derivative cell lines all stained with antibodies to rat S100A4 to a variable degree. The most intense staining for S100A4 was located in tumour cells at the peripheries of the lesions, particularly at the invading edges (Figure 5b , c) and in micrometastases which often surrounded blood vessels in the lungs (Figure 5d ). In this respect, staining with antibodies to S100A4 could detect more readily (Figure 5f ) in the lungs of S5-R37 tumourbearing rats. There was little or no staining of S3-R37 transfectant-cell tumours or parenchymal lung tissue at the concentrations of S100A4 antibody employed (not shown).
Discussion
The results presented in this paper are the ®rst demonstration that transfection of the human gene for the calcium-binding protein, S100A4, into benign rat mammary cells induces metastatic capability in at least some of the cells, a property which it shares with the rat S100A4 gene . The transfection frequencies for pSV2neo-mediated transfection of Rama 37 cells are of the order of 10 74 to 10
75
, in agreement with values obtained previously in this system (Jamieson et al., 1990a, b) . The representative transfected cell lines retain the ability to grow in the presence of Geneticin even after passaging through the animals. They are therefore likely to contain an integrated form of the neo gene which is expressed and functional (Wigler et al., 1979) . The integration of multiple copies of the plasmid pSV2neo and human S100A4 gene into S5-R37 and S3-R37 cells has been con®rmed by slot hybridization with a S100A4 probe. Transfection of 50 copies of the human S100A4 gene into Rama 37 cells also gives rise to increased expression of the corresponding mRNA in S5-R37, whereas the 15 copies in S3-R37 transfectants do not (Figure 2) . Transfection of multiple copies of the S100A4 gene did not signi®cantly increase the tumour incidence relative to the parental Rama 37 cells and reduced their latent period in both the S3-R37 and S5-R37 transformants, but only the transformants expressing high levels of S100A4 mRNA produced metastases in the lungs. The high level of expression of S100A4 is maintained in the S5-R37 tumours and metastases in vivo when determined by immunocytochemistry. Cell lines overexpressing S100A4 from primary tumours and lung metastases produced by S5-R37 cells also retained the ability to induce metastasis and overexpress S100A4 in their lesions when reintroduced into the mammary Bars=50, 200, 50, 50, 25 and 20 mm, respectively fat pads of syngeneic rats. These results suggest that a high level of expression of the S100A4 gene is responsible for metastatic spread to the lungs in this animal system. Further metastatic spread may require additional genetic changes.
The tumours which arise in the animals from the S100A4 gene transfected cells are dierent from those produced by the parental Rama 37 cells. The S5-R37 transfectants no longer consist of relatively benign glandular elements containing both epithelial and myoepithelial-like cells (Rudland, 1993) , but instead, consist of malignant-looking, highly-invasive, spindle/ intermediate cells. These malignant-appearing spindle/ intermediate cells still retain markers detected immunocytochemically for epithelial cells, e.g. milk fat globular membrane, keratins and the receptor for peanut lectin, whereas the main marker for the myoepithelial cells, smooth muscle actin, is entirely lost, and another, laminin, is dramatically reduced (Rudland, 1993) . However, one marker of both myoepithelial and mesenchymal cells is retained, that of vimentin (Warburton et al., 1989) . The changed subcellular location of milk fat globule membrane antigen and the receptor for peanut lectin from a predominantly membranous to a more cytoplasmic distribution (Sloane and Ormerod, 1981) and the expression of vimentin (Ramaekers et al., 1983) are features which are also observed in malignant epithelial cells of some human breast carcinomas (Rudland, 1993) . Although staining for laminin is largely lost in these malignant cells there is an apparent increase in the number of laminin-staining vessels particularly at the leading edges of tumours/metastases. Immunocytochemical staining for S100A4 suggests that this protein is also expressed more strongly at the leading edges of tumours/ metastases where their constituent cells are in contact with the host parenchymal tissue. In addition small micrometastases and single tumour cells are observed in the lungs of S5-R37 tumour-bearing rats, and these lesions can be recognized more easily by immunocytochemical staining for S100A4. Their occurrence in vascular spaces adjacent either to blood cells or to lymphocytes suggests that they may have spread to the lungs from the primary tumour via both blood vessels and lymphatics, perhaps similar, in this respect, to the pattern of spread of human breast cancer (Kamby, 1990) . The decreased latent period for the formation of primary tumours produced by Rama cells transfected with foreign DNA, particularly after passage of the transfected cells in rats, has been noted previously (Davies et al., , 1994 Jamieson et al., 1990a) .
Simple Northern hybridizations using the human gene as a probe, as well as the antibody to rat S100A4, cannot distinguish between expression of the endogenous rat gene and that of the transfected human genes for S100A4. In order to establish that the metastatic phenotype does not arise from the induction of the rat S100A4 in the transfected cells, a PCR method has been developed which distinguishes the mRNA products of the rat and human S100A4 genes. The results clearly show that in the human S100A4 gene transfectants, the level of rat S100A4 mRNA is not elevated over that found in the non-metastatic cells arising from transfection of Rama 37 cells with pSV2neo. However, the transfectants with metastatic capability express elevated levels of human S100A4 mRNA, whereas non-metastatic transfectants containing both the S100A4 gene and pSV2neo or pSV2neo alone do not express elevated levels of the human S100A4 mRNA. It is not possible to test directly the levels of human and rat S100A4 proteins in these cells, since, so far, it has not been possible to raise antisera to S100A4 which distinguish unambiguously the human and rat proteins. However, in all cell lines tested in this laboratory, the level of S100A4 protein is broadly re¯ected in the level of its mRNA (Barraclough et al., 1984a,b; Davies et al., 1993) .
It is unlikely that the ability of the rat and human S100A4 genes to induce the metastatic phenotype is a unique property of the Rama 37 cells. Elevated levels of rat S100A4 from transgenes in transgeneic mice confer the metastatic phenotype, principally metastasis to lungs, on essentially non-metastatic mammary tumours arising from the expression in the same mice of the activated neu oncogene (Davies et al., 1996) . In addition, mouse S100A4 (mts1) transgenes induce metastasis in primary tumours when expressed in a mouse strain exhibiting a strong predisposition for mammary tumours . In addition, the murine S100A4 (mts1) gene is able to induce invasive properties and lung metastasis in nonmetastatic human MCF-7 cells tested in a nude mouse model . This result strongly suggests that human breast cancer cells possess the capability of becoming metastatic, at least to lungs, under the in¯uence of S100A4. Thus, these results, taken together with those in the present paper, strongly suggest that elevated S100A4 might be associated with the development of metastasis in malignant human cancer cells.
That the human gene for S100A4 can induce metastasis in benign tumours in rats suggests that there is strong conservation of the mechanism involved in the metastasis-inducing process. The precise nature of this mechanism in human cells is not known at present; however, evidence is accumulating that in rodent cells, S100A4 interacts with components of the actin/myosin cytoskeleton (Flynn et al., 1996; Ford and Zain, 1995; Kriajevska et al., 1994; Takenaga et al., 1994; Watanabe et al., 1993) . This evidence strongly suggests a role for S100A4 in cell motility, and it is therefore likely that the cellular cytoskeleton and cell motility are involved in the induction of metastasis by human S100A4 as well.
Materials and methods
Cell culture
The cell line, Rama 37 (Dunnington et al., 1983) , and the various transfected derivative cell lines were grown in routine medium comprising Dulbecco's modi®ed Eagles' medium, 5% (v/v) foetal calf serum, 50 ng ml 71 hydrocortisone and 50 ng ml 71 insulin, and passaged upon reaching a con¯uency of approximately 70%.
Nucleic acid isolation and plasmid preparation
The plasmid pSV2neo (Southern and Berg, 1982 ) was a gift from Dr I Summerhayes (ICR, London, UK). Plasmid DNA was isolated from host E. coli strain XL1blue (Stratagene) by preparative alkaline lysis following standard procedures (Sambrook et al., 1989) . Human lymphocyte DNA was a gift of Drs J Quail and SW Edwards (School of Biological Sciences, University of Liverpool, UK).
Cloned human genomic DNA containing the S100A4 gene was isolated from a normal human genomic library, constructed from the DNA of the placenta of a Caucasian male, and cloned into the bacteriophage lFix II (Stratagene). A total of 1.3610 6 recombinant 'phage were cultured as plaques upon the E. coli strain XL1blue MRA(P2). Bacteriophage were transferred to Plaquescreen membrane (DuPont, NEN) by capillary action, lysed, and the bound DNA subjected to hybridization procedures according to the manufacter's instructions. The membrane was incubated with 25 ng of a cloned 202 bp DNA fragment corresponding to exon 2 of the rat S100A4 gene (nucleotide pairs 1968 to 2150 according to Barraclough et al., 1987b) , and radioactively-labelled to a speci®c activity of 1 ± 5610 9 d.p.m./mg DNA (Feinberg and Vogelstein, 1984) . Membranes were washed under conditions of moderate stringency (16SSC, 0.1% SDS) prior to the detection of the hybridized radioactive DNA by autoradiography. Subsequent rounds of bacteriophage plaque puri®cation, isolation of DNA from puri®ed bacteriophages and its restriction enzyme analysis, DNA sequencing and molecular cloning were carried out using established methods (Sambrook et al., 1989) .
One clone of bacteriophage, l4.14, contained a 23 kbpgenomic insert which contained DNA homologous to the rat exon two probe. Fine mapping of the DNA located the DNA homologous to the S100A4 gene on a 2.8 kbp BamHI to NotI fragment, which was subsequently subcloned into the plasmid vector pBluescript SK + . This fragment consisted of DNA between base pairs 4242 and 7367 of the human sequence of Engelkamp et al. (1993) (GenBank accession number Z18950) and contained the three exons of the S100A4 gene, 246 bp of 3' sequence downstream of the poly(A)-addition sequence and 694 bp of sequence upstream of the ®rst exon of the S100A4 gene. However, to ensure that there were no potential upstream regulatory regions of the S100A4 gene absent from this fragment which might compromise expression of the S100A4 gene upon transfection into the recipient rat mammary cell line, Rama 37, a 2.58 kbp BamHI fragment of adjacent upstream DNA, carrying a region of potential upstream transcriptional control elements, was cloned into the above construct 5' of the S100A4 gene to form pBL307. The correct orientation of the inserted BamHI fragment was con®rmed by restriction with BglI and subsequent DNA sequence analysis.
Transfection of plasmid DNA into cultured cells
Exponentially growing cell cultures consisting of 10 6 Rama 37 cells per 9 cm dish, were incubated for 4 h at 378C in 10 ml of routine medium in the presence of a calcium phosphate-DNA precipitate as described previously (Graham and van der Eb, 1973) . The precipitate was formed by bubbling air through a solution of 25 mM N-2-hydroxyethyl piperazine-N'-2-ethane sulphonic acid (HEPES), pH 7.10, 140 mM sodium chloride, 0.75 mM sodium hydrogen phosphate, 125 mM calcium chloride, 20 mg ml 71 supercoiled plasmid DNA (2 mg ml 71 pSV2neo and 18 mg ml 71 pBL307). The medium was replaced with 10% (w/v) dimethylsulphoxide in routine medium at ambient temperature for 90 s (Spandidos and Wilkie, 1984) , and the cells were washed and incubated with routine medium at 378C for 24 h.
Transfected cells were selected by passaging a 1 : 10 dilution of the cells in routine medium supplemented with 1 mg ml 71 Geneticin. Surviving colonies were visible after 10 ± 14 days and were pooled to give stocks of cells for freezing.
DNA hybridization
High-molecular-weight genomic DNA was isolated from the cell line, Rama 37, and transfected derivative cells using standard procedures (Sambrook et al., 1989) . For slot-blot hybridization of DNA to quantify the number of copies of transfected human S100A4 genes, ®vefold dilutions of high-molecular-weight genomic DNA were denatured by heating to 958C for 5 min before being chilled on ice. One volume of 206SSC (3.6 M NaCl, 0.2 M sodium phosphate, 0.02 M EDTA pH 7.7) was added before application of the DNA to Hybond N membrane (Amersham International, UK, Bucks) within a slot-blot manifold (Scotlab). Once applied, DNA was ®xed onto the membrane by UV irradiation (0.15 J sq cm 71 ). A fragment of the human S100A4 gene corresponding to part of intron 2, the entire exon 3 and 153 bp of DNA downstream of the poly(A)-addition sequence, nucleotides 6487 ± 7274 bp of Engelkamp et al. (1993) was excised from an agarose gel for use as a hybridization probe. 25 ng of the DNA was radioactively labelled with a-32 P-dCTP, using the method of random-primed synthesis (Feinberg and Vogelstein, 1984) to a speci®c activity of 2.4610 9 d.p.m. per mg of DNA. Hybridization of the probe to the target sequence was performed according to the instructions of the manufacturer of the membrane, using conditions of high stringency. Hybridization signals were detected by autoradiography.
Analysis of S100A4 mRNA levels by Northern blotting and semi-quantitative reverse transcript polymerase chain reaction Total RNA was extracted from the pooled transfected cell lines using the guanidinium thiocyanate, caesium chloride method (Barraclough et al., 1987a; Chirgwin et al., 1979; Han et al., 1987) . Agarose gel electrophoresis in the presence of formaldehyde, transfer of RNA to Nylon ®lters and hybridization to cDNA, radioactively labelled as described above, were carried out using standard methods (Sambrook et al., 1989) . For reverse transcript polymerase chain reaction (RT ± PCR), cDNA was synthesized using SuperScript RT, RNase H 7 reverse transcriptase (Gibco BRL), according to the manufacturer's instructions, from 1 mg of total RNA which had been annealed with oligo (dT) 17 . S100A4 sequences were ampli®ed from one twentieth of the reverse transcription reaction by PCR using the primers: p9H5': CAGATCCTGACTGCTGC-CATGGCG and p9H3': ACGTGTCTGAAGGAGC-CATGGTGG, which ampli®ed a 420 bp region of human S100A4 mRNA (Engelkamp et al., 1992) and primers p9R5': TTCCACAAATACTCAGGCAAC and p9R3': CACCCACAATCTCCAGTCTCTC which ampli®ed a 418 bp region of the rat S100A4 (p9Ka) mRNA. The conditions of PCR used for both sets of primers were: 948C for 60 s to denature DNA prior to thermal cycling at 948C for 60 s, 558C for 30 s and 728C for 60 s for 20 cycles. The PCR reactions were repeated ®ve times.
Quantitation of cDNA levels was performed following electrophoresis of PCR products by scanning photographic negatives of agarose gels with a Shimadzu C9000¯ying spot densitometer using a beam size of 0.465 mm at a wavelength of 600 nm. The peak areas were determined by integration. The level of S100A4 cDNA for each sample was expressed relative to the peak area of the signal obtained from the lowest S100A4 mRNA-expressing pool of transfectants.
Assay for metastasis
Cultured cells were harvested by digestion with EDTA/ trypsin solutions, washed three times in ice-cold phosphatebuered saline (PBS) and resuspended in PBS at a density of 10 7 cells ml 71 . Female Furth-Wistar rats (Ludwig-Wistar OLA strain, Olac, Banbury, Oxon, UK) of 5 ± 10 weeks of age were injected subcutaneously into the right inguinal mammary fat pad with 2610 6 cells . The rats were observed every 2 ± 3 days throughout the subsequent 12-week experimental period. Necropsies were performed either when the primary tumour reached a size of 5 cm in diameter, or earlier if the tumour showed signs of ulceration or the rat became moribund. The lungs, lymph nodes, liver, spleen and kidney were examined for the presence of gross metastases. Abnormal tissue samples were ®xed in Methacarn (methanol-Inhibisol-acetic acid in a ratio of 6 : 3 : 1) and embedded in paran wax. The histology of 4 mm tissue sections was determined after staining with haematoxylin and eosin and ®ve microscopic ®elds from two sections of each tumour/tissue were examined by two independent observers for the presence of either the primary tumour or for the presence of metastases .
Tumour cells from metastases were re-established in culture by incubation of tissue/excised tumours with collagenase and hyaluronidase in routine medium initially, and then in Geneticin-containing routine medium (Jamieson, 1987) . The metastatic properties of the cell lines established from metastases were con®rmed by being injected into the mammary fat pads of syngeneic rats and subsequent histological examination upon necropsy as described above.
The cytological classi®cation of the benign Rama 37 tumours was based upon normal nuclear to cytoplasmic ratios, little cellular pleiomorphism and the lack of aberrant mitotic ®gures. The vast majority of tumours were surrounded by a ®brous capsule showing little de®nite extracapsular invasion or in®ltration and no evidence of metastases (Dunnington et al., 1983) . 
Immunocytochemistry
The Methacarn-®xed and paran-embedded sections were dewaxed and processed as previously described (Warburton et al., 1982) . They were incubated with 1/600 rabbit antimouse laminin, 1/250 rabbit anti-human callus keratin, 1/ 6000 rabbit anti-rat milk fat globule membrane after prior treatment with pronase (Warburton et al., 1982) , with 1/50 horseradish peroxidase-conjugated peanut lectin after prior treatment with neuraminidase (Newman et al., 1979) or with 1/250 mouse monoclonal antibody (MAb) to smooth muscle actin (Cambridge BioScience, Cambridge: C34931), 1/50 MAb to vimentin (Dako Ltd, Bucks: M0725), 1/750 rabbit anti-rat recombinant S100A4 (p9Ka) (Gibbs et al., 1995) . The primary antibodies were detected using commercially-available antibody complexes containing horseradish peroxidase (Hsu et al., 1981) (Dako Ltd, Bucks) , with the appropriate anti-rabbit or anti-mouse biotinylated secondary antibodies (Amersham Int, Bucks), as described previously (Gibbs et al., 1995) . The bound antibody complexes and conjugated lectin were visualized as a brown stain by incubating the sections with diaminobenzidine and the cell nuclei were counterstained blue with hemalum. The stained sections were examined as for histology and all photographs were recorded with a Kodak Wratten #44 ®lter. Control sections incubated with antibody absorbed with the requisite antigen in place of the primary antibody (Gibbs et al., 1995; Warburton et al., 1982) and with the speci®c competing sugar for peanut lectin (Newman et al., 1979) , all failed to stain.
